NCT07106125View on ClinicalTrials.gov

Antibiotics for Kidney Transplant Recipients

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 30, 2026

Primary Completion Date

December 31, 2028

Study Completion Date

January 31, 2029

Conditions
Kidney TransplantUrinary Tract Infection(UTI)Antibiotic ProphylaxisRemote Patient MonitoringFeasibility Pilot Study
Interventions
DRUG

Trimethoprim-Sulfamethoxazole (TMP-SMX)

Kidney transplant recipients will continue to take TMP-SMX daily from months 6-12 after transplant

OTHER

Usual Care

Participants will take a placebo from months 6-12 after transplant and continue to receive all standard usual care related to their kidney transplant status

Trial Locations (1)

94158

University of California, San Francisco, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER